Goldman Sachs Group Inc Pardes Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 14, 2024
BUY
$1.4 - $1.95 $31,032 - $43,223
22,166 Added 2.72%
838,362 $1.52 Million
Q2 2023

Aug 14, 2023
BUY
$1.4 - $1.95 $31,032 - $43,223
22,166 Added 2.72%
838,362 $1.52 Million
Q1 2023

May 14, 2024
SELL
$1.21 - $2.22 $1.65 Million - $3.04 Million
-1,367,207 Reduced 62.62%
816,196 $1.08 Million
Q1 2023

May 11, 2023
SELL
$1.21 - $2.22 $1.65 Million - $3.04 Million
-1,367,207 Reduced 62.62%
816,196 $1.08 Million
Q4 2022

May 14, 2024
SELL
$0.85 - $1.69 $3.1 Million - $6.16 Million
-3,646,268 Reduced 62.55%
2,183,403 $3.69 Million
Q4 2022

Feb 13, 2023
SELL
$0.85 - $1.69 $3.1 Million - $6.16 Million
-3,646,268 Reduced 62.55%
2,183,403 $3.69 Million
Q3 2022

May 14, 2024
BUY
$2.14 - $3.7 $3.33 Million - $5.75 Million
1,553,757 Added 36.34%
5,829,671 $10.8 Million
Q3 2022

Nov 10, 2022
BUY
$2.14 - $3.7 $3.33 Million - $5.75 Million
1,553,757 Added 36.34%
5,829,671 $0
Q2 2022

May 14, 2024
BUY
$2.84 - $8.57 $12.1 Million - $36.6 Million
4,275,914 New
4,275,914 $13.1 Million
Q2 2022

Aug 15, 2022
BUY
$2.84 - $8.57 $6.14 Million - $18.5 Million
2,163,503 Added 102.42%
4,275,914 $13.1 Million
Q1 2022

May 16, 2022
BUY
$5.64 - $15.64 $11.9 Million - $33 Million
2,112,411 New
2,112,411 $15.3 Million

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0
View Full List

About PARDES BIOSCIENCES, INC.

PRDS Quotes by TradingView
  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email